News from the FDA/CDC
News from the FDA/CDC
FDA approves triple drug combo for melanoma
News from the FDA/CDC
EMA gives green light to avapritinib for GIST, acalabrutinib for CLL
The Committee for Medicinal Products for Human Use has given a favorable opinion on both drugs.
News
FDA approves oral therapy for myelodysplastic syndromes, CMML
Under a priority review, the FDA approved a combination tablet for treatment of people with myelodysplastic syndromes or chronic myelomonocytic...
News from the FDA/CDC
Use of nonopioid pain meds is on the rise
Prescription opioid use declined from 2009 to 2018, but not significantly.
News from the FDA/CDC
FDA approves avelumab as maintenance for urothelial carcinoma
News from the FDA/CDC
FDA approves new indications for pembrolizumab
News from the FDA/CDC
Pembro approved for first-line use in MSI-H/dMMR colorectal cancer
This is the first time an immunotherapy has been approved in this setting and as monotherapy.
News from the FDA/CDC
FDA approves in-home breast cancer treatment
News from the FDA/CDC
COVID-19: Medicare data show long hospital stays, disparities
Many beneficiaries “face structural challenges to their health,” said CMS Administrator Seema Verma.
News
FDA approves selinexor for relapsed/refractory DLBCL
News from the FDA/CDC
FDA gives thumbs up to tazemetostat for follicular lymphoma